Suzhou Novoprotein Scientific Co (SHSE:688137) Total Liabilities: ¥124.8 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688137 Suzhou Novoprotein Scientific Co Ltd SHSE:688137
62 GF Score
Price ¥34.76
GF Value ¥37.73
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Suzhou Novoprotein Scientific Co Total Liabilities?

Suzhou Novoprotein Scientific Co SHSE:688137 +1.67% 62 Total Liabilities is ¥124.8 Mil as of Mar. 2026. GuruFocus rates SHSE:688137 with a GF Score™ of 62/100 and a GF Value™ of ¥37.73 (Fairly Valued). The stock has 2 warning signs investors should review.

Suzhou Novoprotein Scientific Co's Total Liabilities for the quarter that ended in Mar. 2026 was ¥124.8 Mil.

Suzhou Novoprotein Scientific Co's quarterly Total Liabilities increased from Sep. 2025 (¥114.78 Mil) to Dec. 2025 (¥116.83 Mil) and increased from Dec. 2025 (¥116.83 Mil) to Mar. 2026 (¥124.85 Mil).

Suzhou Novoprotein Scientific Co's annual Total Liabilities increased from Dec. 2023 (¥110.43 Mil) to Dec. 2024 (¥116.44 Mil) and increased from Dec. 2024 (¥116.44 Mil) to Dec. 2025 (¥116.83 Mil).

Suzhou Novoprotein Scientific Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for Suzhou Novoprotein Scientific Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suzhou Novoprotein Scientific Co Total Liabilities Chart

Suzhou Novoprotein Scientific Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 153.33 133.22 110.43 116.44 116.83

Suzhou Novoprotein Scientific Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 121.65 116.44 114.78 116.83 124.85
SHSE:688137
62GF Score
Suzhou Novoprotein Scientific Co Ltd SHSE:688137
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Suzhou Novoprotein Scientific Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Suzhou Novoprotein Scientific Co's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=69.122+(45.601+2.103
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=116.8

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=2151.549-2034.722
=116.8

Suzhou Novoprotein Scientific Co's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=79.032+(43.4+2.417
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=124.8

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=2145.885-2021.036
=124.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ¥124.8 Mil mean?
Suzhou Novoprotein Scientific Co (SHSE:688137) has a Total Liabilities of ¥124.8 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Suzhou Novoprotein Scientific Co and its competitors.
Is Suzhou Novoprotein Scientific Co's Total Liabilities too high?
Suzhou Novoprotein Scientific Co's current Total Liabilities is ¥124.8 Mil. Overall, Suzhou Novoprotein Scientific Co has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Suzhou Novoprotein Scientific Co's Total Liabilities compare to VRTX and REGN?
Suzhou Novoprotein Scientific Co's Total Liabilities of ¥124.8 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Suzhou Novoprotein Scientific Co and its competitors. Suzhou Novoprotein Scientific Co's current Total Liabilities is ¥124.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Novoprotein Scientific Co stock overvalued right now?
Based on GuruFocus' analysis, Suzhou Novoprotein Scientific Co (SHSE:688137) is currently considered Fairly Valued. The stock's GF Value™ is ¥37.73, compared to a current price of ¥34.76 — trading 7.9% below its estimated fair value. The current Total Liabilities is ¥124.8 Mil. Suzhou Novoprotein Scientific Co's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Suzhou Novoprotein Scientific Co (SHSE:688137), the current Total Liabilities is ¥124.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Suzhou Novoprotein Scientific Co (SHSE:688137) Overvalued in 2026?

Based on GuruFocus' analysis, Suzhou Novoprotein Scientific Co stock appears to be undervalued. The current stock price of ¥34.76 is trading 7.9% below its estimated GF Value™ of ¥37.73. GuruFocus considers Suzhou Novoprotein Scientific Co to be Fairly Valued.

Key valuation signals for SHSE:688137:

  • Total Liabilities: ¥124.8 Mil
  • GF Value™: ¥37.73 vs. price of ¥34.76 (7.9% below fair value)
  • GF Score™: 62/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688137 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Suzhou Novoprotein Scientific Co Business Description

Address No. 228, Yunchuang Road, 3rd & 4th Floor, Wujiang Economic and Technological Development Zone, Jiangsu Province, Suzhou, CHN, 215299
Suzhou Novoprotein Scientific Co Ltd is a high-tech enterprise focusing on recombinant protein application solutions. Its main business is the research and development of target and cytokine proteins, recombinant antibodies, enzymes, and reagents, Production and sales, and providing related technical services.
62GF Score

Get the complete analysis for SHSE:688137

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥34.76
Price
¥37.73
GF Value